NeoPhore raised €6.8M in a Series B round in Jan 2023. The company is based in Cambridge, UK. Investors in the round: 2Invest, 3B Future Health Fund, Astellas Venture Management and 2 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
